Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$195,118,133
+$133,872,949 QoQ
Shares Held
775,386
+175.4% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#163
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $1,536,520,507 across 9 Drug Manufacturers - General names. ABBV ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,162,034 | $549,091,774 | |
| 2 | LLY |
ELI LILLY & Co
|
396,979 | $476,148,561 | |
| 3 | AZN |
Astrazeneca PLC
|
1,215,636 | $230,508,898 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
775,386 | $195,118,133 | |
| 5 | MRK |
Merck & Co., Inc.
|
520,333 | $66,862,790 | |
| 6 | NVS |
Novartis AG
|
51,084 | $8,005,884 | |
| 7 | PFE |
Pfizer Inc
|
235,637 | $5,674,138 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,979 | $3,052,649 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $195,118,133 | 775,386 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $61,245,184 | 281,600 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $23,104,908 | 101,120 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,178,139 | 18,045 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,821,915 | 20,590 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,667,569 | 7,959 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,519,335 | 8,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $26,872,683 | 136,078 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,075,691 | 122,876 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $147,657,606 | 810,860 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,114,870 | 58,817 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,638,474 | 57,953 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,406,175 | 40,126 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,245,737 | 64,289 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,893,992 | 24,095 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,401,415 | 40,246 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,668,586 | 43,540 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $35,115,295 | 216,614 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,521,283 | 18,621 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,217,330 | 29,826 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,960,161 | 17,402 | Shares | Sole | 2021-08-20 | |
| 2021-03-31 | $829,830 | 7,668 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $47,495,737 | 443,264 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,769,130 | 77,282 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $27,719,355 | 282,332 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,470,969 | 84,932 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||